GILMORE CHUNG: Open Payments
NPI 1992027072 · VENICE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$111 in 5 payments from 3 companies in 2025. Trend: 2023 $87 · 2024 $94 · 2025 $111
Food & beverage: $111
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 3 | $59 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $27 |
| Abbott Laboratories | 1 | $25 |
Products named: CAPLYTA, FREESTYLE LIBRE 3.
Industry payments across CA — which companies pay providers there.
